Growth risks in children with thalassemia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at what factors might affect growth in children with beta-thalassemia major who get regular blood transfusions. It aims to help understand and manage growth problems better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 18 years old
- You have been diagnosed with beta-thalassemia major
- You get regular blood transfusions as part of your care
- You have been coming to the hematology clinic at Assiut University Children's Hospital for at least one year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how thalassemia and its treatments affect puberty and hormone function in teens aged 10 to 18. It aims to understand and possibly improve care for these young patients.
This study looks at body composition in children with thalassemia major who receive regular blood transfusions. It aims to understand how the condition and treatment affect body fat, muscle, and overall health.
This study looks at how children with transfusion-dependent beta-thalassemia grow and develop after gene therapy. It compares children who have had gene therapy with those who have not, and also with healthy children of the same age and gender.
This study looks at how severe thalassemia is in children and teens. If your child has thalassemia and is between 18 months and 18 years old, joining may help doctors better understand the condition.
This study looks at the medical, financial, and emotional impact of thalassemia on children and their families. It aims to understand the burden of the disease to improve support and care.
This trial tests a modified, lower-toxicity preparation (conditioning) before a bone marrow transplant in children and teens with high-risk thalassemia. It aims to reduce treatment side effects while still allowing transplant success for people who need a donor.
Hear when a new Thalassemia Majors (Beta-Thalassemia Major) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.